According to researchers from Universidad de Chile, a cannabidiol (CBD) oil-in-water nanoemulsion shows promising antitumor effects in canine mammary carcinoma cell lines. The formulation, known as CBD-Nem, was created to overcome CBD’s poor solubility in water, which normally requires solvents like ethanol or dimethylsulfoxide that can restrict safe dosing. By incorporating CBD into nanoemulsions using …
Category: Studies
Study Finds CBD Enhances Effectiveness of FGFR Inhibitors in Colorectal Cancer Treatment
A recent study has found that pairing cannabidiol (CBD) with fibroblast growth factor receptor (FGFR) inhibitors could provide a more effective therapy for treating colorectal cancer, which is one of the deadliest forms of cancers worldwide. The study was published in the peer-reviewed journal Nutrients, and was conducted by researchers at Korea University College of …
Study: Cannabis, Both High-CBD and High-THC, May Improve Metabolic Health in Obesity
In a study by researchers from Wake Forest University School of Medicine, the University of North Carolina, and the University of South Carolina School of Medicine, cannabis with both high CBD or high THC improved key markers of metabolic and immune health in an animal model of obesity. In the study, published in the American …
Study of 20 Countries Finds Medical Cannabis Legalization Associated With Reduction in Tobacco and Amphetamine Use
A new study covering 20 countries, published in the Journal of Cannabis Research and the U.S. National Library of Medicine, finds that medical cannabis legalization is associated with a large reduction in tobacco and amphetamine use. “Amidst the global shift toward cannabis legalization, this study examines medical cannabis (MC) sales as an indicator of economic …
Study: Psilocybin Therapy Linked to 5-Year Remission in Majority of Depression Patients
A new long-term study published in the Journal of Psychedelic Studies has found that psilocybin-assisted therapy (PAT) produced lasting relief from depression in patients with Major Depressive Disorder (MDD), with many remaining in remission five years after treatment. The research followed 21 participants from an earlier clinical trial, with 18 completing the five-year follow-up. Results …
Study: Cannabis-Derived Packaging Helps Preserve Grape Quality by Slowing Anthocyanin Degradation
Researchers in Poland have developed biodegradable packaging films infused with pollen extract from Cannabis sativa L., showing they can extend the shelf life and protect the quality of grapes. The study, published in the journal Colloids and Surfaces B: Biointerfaces, tested polysaccharide-based films incorporating cannabis pollen extract as an alternative to conventional petroleum plastics. Thompson …
Study: Medicinal Cannabis Could Help Reduce Opioid Deaths and Address Global Health Inequities
A comprehensive review published in the journal Complementary Therapies in Medicine examines how medicinal cannabis could address the opioid crisis and global health disparities. The study includes contributions from researchers at Johns Hopkins University, the University of Pennsylvania, Imperial College London, Harvard, and several others.
Study: Cannabis Use Not Independently Linked to Head and Neck Cancer, Unlike Alcohol and Cigarettes
A new study published in the Journal of Oral Pathology & Medicine by researchers from the University of Florida examined whether cannabis use contributes to the risk of head and neck cancers. The analysis, which relied on hospital data accessed through the i2b2 platform and ICD-10 codes, found that while cannabis users initially showed higher …
Study: Medical Cannabis Improves Quality of Life for Cancer Patients
A new review published in the Journal of Integrative and Complementary Medicine has found that medical cannabis can improve the quality of life for cancer patients. Researchers at Universidade Federal de São Paulo analyzed 267 studies and narrowed them down to 16 that met their strict criteria for inclusion.
Study: CBD Reduces Seizures in 68% of Patients, With Genetic Variants Influencing Response
A new study published in Frontiers in Pharmacology found that CBD reduced seizure frequency in 68% of patients with drug-resistant epilepsy, with genetic differences possibly explaining why some do not respond. Researchers in Mexico analyzed 47 pediatric and adult patients who had incorporated CBD into their treatment plans for at least six months. All patients …













